Form 4: USANA Health Sciences Executive David Mulham Reports Acquisition of Restricted Stock Units

David Mulham, Chief Sales Officer of USANA Health Sciences, reports the acquisition of 18,641 restricted stock units.

Summary

• On February 27, 2025, David Mulham, Chief Sales Officer of USANA Health Sciences, acquired 18,641 restricted stock units.
• These restricted stock units represent a contingent right to receive one share of USNA common stock each.
• The restricted stock units vest at a rate of 25% on each February 27th, starting in 2026.
• Following the reported transaction, Mulham directly owns 32,671 shares of USNA common stock.
• The transaction was reported on March 3, 2025.

Sentiment

Score: 7

Explanation: The acquisition of restricted stock units by a key executive is generally a positive sign, indicating confidence in the company's future. However, it's a routine transaction, so the sentiment is moderately positive.

Positives

• The acquisition of restricted stock units by a key executive signals confidence in the company's future performance.

Future Outlook

The vesting schedule of the restricted stock units suggests a multi-year commitment by the executive to the company's success.

Industry Context

Stock grants are a common form of executive compensation in the health and wellness industry, aligning management's interests with those of shareholders.

Comparison to Industry Standards

• Executive compensation packages, including stock options and restricted stock units, are standard practice among publicly traded companies like USANA Health Sciences.
• Comparable companies such as Herbalife Nutrition and Nu Skin Enterprises also utilize stock-based compensation to incentivize and retain key executives.
• The vesting schedule of 25% annually is a typical vesting arrangement for restricted stock units.

Stakeholder Impact

• The acquisition of restricted stock units by a key executive can positively influence shareholder sentiment.
• The vesting schedule incentivizes the executive to contribute to the company's long-term success, benefiting shareholders.

Key Dates